- Home
- EZGO vs SCNI Comparison
EZGO vs SCNI Comparison
Compare EZGO & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- SCNI
- Stock Information
- Founded
- EZGO 2014
- SCNI 2003
- Country
- EZGO China
- SCNI Israel
- Employees
- EZGO N/A
- SCNI N/A
- Industry
- EZGO Motor Vehicles
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EZGO Consumer Discretionary
- SCNI Health Care
- Exchange
- EZGO Nasdaq
- SCNI Nasdaq
- Market Cap
- EZGO 2.0M
- SCNI 1.9M
- IPO Year
- EZGO 2021
- SCNI N/A
- Fundamental
- Price
- EZGO $0.36
- SCNI $2.55
- Analyst Decision
- EZGO
- SCNI
- Analyst Count
- EZGO 0
- SCNI 0
- Target Price
- EZGO N/A
- SCNI N/A
- AVG Volume (30 Days)
- EZGO 1.9M
- SCNI 1.1M
- Earning Date
- EZGO 06-17-2025
- SCNI 07-01-2025
- Dividend Yield
- EZGO N/A
- SCNI N/A
- EPS Growth
- EZGO N/A
- SCNI N/A
- EPS
- EZGO N/A
- SCNI N/A
- Revenue
- EZGO $21,134,425.00
- SCNI $658,000.00
- Revenue This Year
- EZGO N/A
- SCNI N/A
- Revenue Next Year
- EZGO N/A
- SCNI N/A
- P/E Ratio
- EZGO N/A
- SCNI N/A
- Revenue Growth
- EZGO 32.75
- SCNI N/A
- 52 Week Low
- EZGO $0.29
- SCNI $1.90
- 52 Week High
- EZGO $2.09
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- EZGO 50.72
- SCNI 46.70
- Support Level
- EZGO $0.32
- SCNI $2.32
- Resistance Level
- EZGO $0.39
- SCNI $6.18
- Average True Range (ATR)
- EZGO 0.03
- SCNI 0.41
- MACD
- EZGO 0.00
- SCNI -0.01
- Stochastic Oscillator
- EZGO 69.53
- SCNI 8.10
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.